People. Progressive. Principled

Hologic’s Tepnel Pharma Services Achieves ISO 17025 Accreditation for Extraction and Genotyping Services


Manchester, England, 19 Jan. 2016 – Tepnel Pharma Services (Tepnel), a business unit of Hologic, Inc., announced today that it has been awarded ISO 17025:2005 accreditation for DNA extraction from whole blood using Nucleon chemistry and DNA genotyping using InvaderPLUS by the United Kingdom Accreditation Service (UKAS). This internationally recognised standard provides evidence of the continued commitment and development of the quality systems at Tepnel to provide leading levels of quality assurance and control.

Bob Holt, Sr. Manager, Biomarker and CDx Services for Tepnel Pharma Services, commented: “Accreditation is the next stage in our commitment to leading the field in data integrity and quality assurance. It marks the continued development of our biomarker services, acknowledging our proficiency in this growing area and demonstrating our commitment to improving patient outcomes.”

The ISO 17025:2005 standard is a means of assessing the technical competence and integrity of organisations that offer laboratory services. Accreditation is the final step which recognises that an organisation is competent to perform specific processes, as detailed in a scope of accreditation, in a reliable, credible and accurate manner, underpinning the quality of results by ensuring their traceability, comparability, validity and commutability.

About Tepnel Pharma Services Tepnel Pharma Services

is the Contract Research Organization (CRO) arm of Hologic, Inc. Tepnel specialises in the provision of pharmaceutical testing and biomarker services in support of drug development and companion diagnostics development. Tepnel’s pharmaceutical testing facilities are located in Manchester, England and Livingston, Scotland.

About Hologic

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company’s core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure. For more information on Hologic, visit www.hologic.com.

Hologic, Tepnel Pharma Services, The Science of Sure and associated logos are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.

Forward‐Looking Statements Disclaimer

This press release may contain forward‐looking information that involves risks and uncertainties, including statements about Hologic, Inc., Tepnel Pharma Services and its services. There can be no assurance that Tepnel will successfully market the services described herein, or that they will achieve any specific level of sales. In addition, the results achieved for any individual customer may vary on a case‐by‐case basis. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein or to reflect any change in expectations or any change in events, conditions or circumstances on which any such statements are based.

Contacts:

Carol Smith
Marketing Communications Manager
Hologic, Inc.
carol.smith@hologic.com
Tel: + 44 (0) 161 946 2220

Get in touch

Name

Company

Email

Telephone

Message

captcha